ST-segment Elevation Myocardial Infarction
36
2
3
21
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
2.8%
1 terminated out of 36 trials
95.5%
+8.9% vs benchmark
36%
13 trials in Phase 3/4
19%
4 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (36)
Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction
The Thrombus Aspiration During PCI After Thrombolysis in STEMI
INsTantenous wavE-Free Ratio-guided PCI Versus Fractional Flow REserve-Guided PCI in rouTine Clinical Practice, Prospective, Multicenter Registry
Comparison Between the Effects of High Doses Statin on Ventricular Remodeling in STEMI Patients
The FAVOR V AMI Trial
Henan STEMI Registry
EROSION II: OCT Guided PPCI in STEMI
The Usefulness of CaIMR in Patients With STEMI
Post-Marketing Safety Study in ST-Segment Elevation Myocardial Infarction (STEMI) Participants Undergoing Primary Percutaneous Coronary Intervention (PCI) Procedure With VISIPAQUE® as the Contrast Medium
Remote Ischemic Perconditioning in Patients With ST-segment Elevation Myocardial Infarction
Optimal Coronary Flow After PCI for Myocardial Infarction - a Pilot Study
EROSION III: OCT- vs Angio-based Reperfusion Strategy for STEMI
Sonothrombolysis in Patients With STEMI
The Effect of Glucocorticoid Therapy on Left Ventricular Remodelling in Acute Myocardial Infarction (RECONSIDER)
Effects of Morphine on Loading-dose Ticagrelor in Patients With ST-segment Elevation Myocardial Infarction
Multicentre REtrospective StuDy of Treatment and OUtComes in STEMI Patients in Fujian Province
International Collaboration of Comprehensive Physiologic Assessment
Comparison of Left and Right Transradial Approach for CAG and PCI
Association Between Plasma Melatonin and No-reflow
Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Acute Myocardial Infarction